&Partners’s Synovus SNV Stock Holding History

&Partners’s Portfolio SNV Stock Details SNV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-6,636	Closed	-$332K	–	2461
2025 Q4	$332K	Sell	6,636 -1,160	-15%	-$55.8K	﹤0.01%	1856
2025 Q3	$383K	Buy	7,796 +1,242	+19%	+$63.6K	﹤0.01%	1617
2025 Q2	$339K	Buy	6,554 +243	+4%	+$11.2K	﹤0.01%	1565
2025 Q1	$292K	Sell	6,311 -1,167	-16%	-$60.2K	﹤0.01%	1427
2024 Q4	$388K	Buy	7,478 +286	+4%	+$14.8K	﹤0.01%	1189
2024 Q3	$320K	Buy	7,192 +134	+2%	+$5.86K	0.01%	1072
2024 Q2	$284K	Buy	+7,058	New	+$268K	0.01%	729

Other funds holding SNV

WBWA

William B. Walkup & Associates Columbia, South Carolina $167M AUM 20.75% 1-Year Est. Return

&Partners's SNV Position: Q1 2026 in Review

&Partners sold out of Synovus (SNV) in Q1 2026, closing a stake of 6,636 shares — an estimated $332K sold.

&Partners first reported a position in SNV in Q2 2024 and held it in 7 quarters. The position peaked at $388K in Q4 2024. 1 fund tracked by Wall St. Rank holds SNV as of Q1 2026.

&Partners reported no remaining Synovus position as of Q1 2026 after selling out during the quarter.
&Partners sold 6,636 Synovus shares in Q1 2026, an estimated $332K.
&Partners first reported a position in Synovus in Q2 2024 and held it in 7 quarters.
&Partners's Synovus position peaked at $388K in Q4 2024.
1 fund tracked by Wall St. Rank held Synovus as of Q1 2026.

Based on &Partners's 13F filing for Q1 2026, filed 15 May 2026.